• Molecular NameApraclonidine
  • SynonymApraclonidina [INN-Spanish]; Apraclonidine Hydrochloride; Apraclonidinum [INN-Latin]; P-Aminoclonidine Hydrochloride
  • Weight245.113
  • Drugbank_IDDB00964
  • ACS_NO66711-21-5
  • Show 2D model
  • LogP (experiment)1.53
  • LogP (predicted, AB/LogP v2.0)2.36
  • pkaN/A
  • LogD (pH=7, predicted)0.21
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.64
  • LogSw (predicted, AB/LogsW2.0)0.08
  • Sw (mg/ml) (predicted, ACD/Labs)1.25
  • No.of HBond Donors4
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds2
  • TPSA62.44
  • StatusFDA approved
  • AdministrationOphthalmic solution
  • PharmacologyA sympathomimetic used in glaucoma therapy. It is an α2-adrenergic agonist.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding98.7
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life8 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A